Health system venture groups are far more than finance vehicles on the periphery of care delivery. They serve as high-impact engines for clinical and operational innovation, empowering frontline clinicians, administrators, and care teams to reimagine and improve how care is delivered and experienced. By providing dedicated funding, strategic focus, and governance, these groups accelerate the adoption of breakthrough technologies, expand access to specialized services, and optimize clinical workflows. Their unique access to healthcare environments allows them to validate, implement, and spread impactful innovations faster than traditional investors. The result is better outcomes for patients, reduced burnout for providers, and sustainable growth for the health system. This article explores why ad hoc innovation stalls without governance, how venture capital functions as a capability enabler, and the purposeful design of Intermountain Ventures as a model for other health systems. We also examine concrete examples of successful investments—in areas such as care delivery, access to care, and next-generation technology—and offer a practical playbook for executives looking to launch or refine their own venture programs. Finally, we reflect on the strategic imperative of putting mission-based capital to work, today and in the future, enabling responsible innovation with long-term impact.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: